Overview

Multiple Dose Study to Evaluate Drug-drug Interactions, Safety and Tolerability of NDC-002 in Healthy Volunteers

Status:
Completed
Trial end date:
2023-03-15
Target enrollment:
Participant gender:
Summary
An Open-label, One-sequence, Three-period, Multiple-dose Study to Evaluate Drug-drug Interactions, Safety and Tolerability between NDC-002A/NDC-002B and NDC-002C in Healthy Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Noah Biotech Inc.